Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
Profitability Metrics
Gross Margin
50.28%
Operating Margin
39.81%
Net Margin
4.12%
Efficiency Metrics
Revenue per Expense Ratio
1.66
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
65.97%
Income Tax Rate
0.00%
EPS
0.0392000000
Balance Sheet Analysis
Current Ratio
1.30
Cash Ratio
1.01
Working Capital
$7.48M
Debt to Equity
2.85
Debt to Assets
73.35%
Equity Ratio
25.73%
Cash Flow Analysis
Operating Cash Flow Ratio
25.90%
Free Cash Flow Ratio
-1,140.9%
CapEx to Revenue
1,166.8%
Dividends Paid
No dividends paid
Stock Buybacks
No buybacks
Total Shareholder Returns
No shareholder returns
Cash Position Change
8,356.0%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
0.00%
Net Income
177.18%
EPS
164.26%
Operating Income
845.60%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
96.06%
Operating Cash Flow
793.02%
Free Cash Flow
-436.17%
Balance Sheet Health
Assets
235.57%
Debt
514.62%
Book Value per Share
41.47%
Inventory
0.00%
Shareholder Returns
Dividends per Share
0.00%
Shares Outstanding
20.19%
Long Term Trends
3Y Revenue/Share
0.00%
5Y Revenue/Share
0.00%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%